Trial 1B-16-8


Phase 1b Study to Assess the Safety, Tolerability, and Clinical Activity of Gedatolisib in Combination with Palbociclib and Either Letrozole or Fulvestrant in Women with Metastatic or Locally Advanced/Recurrent Breast Cancer (MBC)

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments: Hormone, Other
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Janice Lu, M.D.
Other Trial Staff:  Richa Aggarwal, D.M., Victoria Banerjee, R.N., Grace Facio, R.N., Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.